The study evaluated the diagnostic value and cost-effectiveness of next-generation
sequencing (NGS)–based testing versus various combinations of single-gene tests (SGTs) for …

Human genetic studies of smoking behavior have been thus far largely limited to common
variants. Studying rare coding variants has the potential to identify drug targets. We performed …

Aims Despite intensive lipid-lowering therapies (LLTs), most patients with homozygous
familial hypercholesterolaemia (HoFH) do not achieve guideline recommended low-density …

Full article: An economic evaluation of tofacitinib for the treatment of moderately-to-severely
active ulcerative colitis: modeling the cost of treatment strategies in the United States Skip to …

Background Prior analyses beyond clinical trials are yet to evaluate the projected lifetime
benefit of apixaban treatment compared to low-molecular-weight heparin (LMWH)/vitamin K …

Though highly efficient at fermenting hexose sugars, Saccharomyces cerevisiae has limited
ability to ferment five-carbon sugars. As a significant portion of sugars found in cellulosic …

Purpose To assess the cost-effectiveness of apixaban versus rivaroxaban, low-molecular-weight
heparin (LMWH)/dabigatran, and LMWH/vitamin K antagonist (VKA) for the initial …

Background and objective Venous thromboembolism (VTE) is associated with long-term
clinical and economic burden. Clinical guidelines generally recommend at least 3 months of …

Objective: We assessed the potential clinical and economic impact of coronary heart disease
(CHD) and diabetes arising after the use of second-generation (“atypical”) antipsychotic …

Objectives Tofacitinib is an oral, small molecule Janus kinase (JAK) inhibitor for the treatment
of ulcerative colitis (UC). This study assessed the cost-effectiveness of tofacitinib versus …